{"id":66393,"date":"2026-04-07T08:50:57","date_gmt":"2026-04-07T03:20:57","guid":{"rendered":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/"},"modified":"2026-04-08T18:45:57","modified_gmt":"2026-04-08T13:15:57","slug":"stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25","status":"publish","type":"post","link":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/","title":{"rendered":"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25"},"content":{"rendered":"<p style=\"text-align: justify;\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/api.newsfilecorp.com\/newsinfo\/291352\/511\" width=\"2\" height=\"2\" \/><\/p>\n<p style=\"text-align: justify;\">Dallas, Texas&#8211;(Newsfile Corp. &#8211; April 6, 2026) &#8211; Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate&#8217;s 4Q25 update continues to position CTx-1301 toward a potential commercial ADHD launch, with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The NDA remains under FDA review under the 505(b)(2) pathway, and recent financing, IP progress, and commercial buildout efforts remain supportive of the broader investment thesis. Importantly, following the $12M PIPE completed in February 2026, the Company has a pro forma cash balance of approximately ~$23M, which we estimate provides runway into late 2026. Combined with ongoing access to capital through its ATM and ELOC facilities, we believe Cingulate is positioned to fund ongoing regulatory and manufacturing activities as it works toward resolution of remaining CMC items.<\/p>\n<p style=\"text-align: justify;\">To view the full announcement, including downloadable images, bios, and more, <a href=\"https:\/\/api.newsfilecorp.com\/redirect\/5Wb8QUWKOK\">click here<\/a>.<\/p>\n<p style=\"text-align: justify;\"><b>Key Takeaways:<\/b><\/p>\n<ul style=\"text-align: justify;\">\n<li>FDA feedback limited to manufacturing\/CMC; no safety or efficacy concerns, positioning remaining work as addressable process validation rather than clinical risk.<\/li>\n<li>Regulatory timing may shift, but approval remains likely; delay driven by manufacturing validation, not fundamental issues with product profile.<\/li>\n<li>Large ADHD market opportunity: ~1% share implies ~$250M revenue potential for CTx-1301, primarily targeting the booster-dose segment, as disclosed by the Company.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/api.newsfilecorp.com\/redirect\/Lqry4tGXZ8\"><img decoding=\"async\" src=\"https:\/\/images.newsfilecorp.com\/files\/7294\/291352_figure1_550.jpg\" alt=\"Cannot view this image? Visit: https:\/\/images.newsfilecorp.com\/files\/7294\/291352_figure1_550.jpg\" \/><\/a><\/p>\n<p style=\"text-align: justify;\"><i>Click image above to view full announcement.<\/i><\/p>\n<hr \/>\n<p style=\"text-align: justify;\"><strong>About Stonegate<br \/>\n<\/strong>Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.<\/p>\n<div style=\"text-align: justify;\">\n<p><b>Contacts:<\/b><\/p>\n<p>Stonegate Capital Partners<br \/>\n(214) 987-4121<br \/>\n<a href=\"mailto:info@stonegateinc.com\">info@stonegateinc.com<\/a><\/p>\n<\/div>\n<p style=\"text-align: justify;\">Source: <a href=\"https:\/\/api.newsfilecorp.com\/redirect\/oPDQkTBkZV\">Stonegate, Inc.<\/a><\/p>\n<p style=\"text-align: justify;\">To view the source version of this press release, please visit <a href=\"https:\/\/api.newsfilecorp.com\/redirect\/OA4NJI21pZ\">https:\/\/www.newsfilecorp.com\/release\/291352<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dallas, Texas&#8211;(Newsfile Corp. &#8211; April 6, 2026) &#8211; Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate&#8217;s 4Q25 update continues to position CTx-1301 toward a potential commercial ADHD launch, with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The NDA remains under FDA review &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32016],"tags":[32296],"class_list":["post-66393","post","type-post","status-publish","format-standard","","category-press-releases","tag-cingulate"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English\" \/>\n<meta property=\"og:description\" content=\"Dallas, Texas&#8211;(Newsfile Corp. &#8211; April 6, 2026) &#8211; Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate&#8217;s 4Q25 update continues to position CTx-1301 toward a potential commercial ADHD launch, with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The NDA remains under FDA review &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/\" \/>\n<meta property=\"og:site_name\" content=\"Matribhumi Samachar English\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-07T03:20:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-08T13:15:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/api.newsfilecorp.com\/newsinfo\/291352\/511\" \/>\n<meta name=\"author\" content=\"Saransh Kanaujia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saransh Kanaujia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/\",\"name\":\"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English\",\"isPartOf\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\"},\"datePublished\":\"2026-04-07T03:20:57+00:00\",\"dateModified\":\"2026-04-08T13:15:57+00:00\",\"author\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\"},\"breadcrumb\":{\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/matribhumisamachar.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#website\",\"url\":\"https:\/\/matribhumisamachar.com\/en\/\",\"name\":\"Matribhumi Samachar English\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1\",\"name\":\"Saransh Kanaujia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g\",\"caption\":\"Saransh Kanaujia\"},\"description\":\"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.\",\"sameAs\":[\"https:\/\/matribhumisamachar.com\/en\"],\"url\":\"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/","og_locale":"en_US","og_type":"article","og_title":"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English","og_description":"Dallas, Texas&#8211;(Newsfile Corp. &#8211; April 6, 2026) &#8211; Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates their coverage on Cingulate Inc. (NASDAQ: CING). Cingulate&#8217;s 4Q25 update continues to position CTx-1301 toward a potential commercial ADHD launch, with the regulatory focus now centered on manufacturing (CMC) rather than clinical performance. The NDA remains under FDA review &hellip;","og_url":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/","og_site_name":"Matribhumi Samachar English","article_published_time":"2026-04-07T03:20:57+00:00","article_modified_time":"2026-04-08T13:15:57+00:00","og_image":[{"url":"https:\/\/api.newsfilecorp.com\/newsinfo\/291352\/511"}],"author":"Saransh Kanaujia","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Saransh Kanaujia","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/","url":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/","name":"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25 - Matribhumi Samachar English","isPartOf":{"@id":"https:\/\/matribhumisamachar.com\/en\/#website"},"datePublished":"2026-04-07T03:20:57+00:00","dateModified":"2026-04-08T13:15:57+00:00","author":{"@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1"},"breadcrumb":{"@id":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/matribhumisamachar.com\/en\/2026\/04\/07\/stonegate-capital-partners-updates-coverage-on-cingulate-inc-cing-4q25\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/matribhumisamachar.com\/en\/"},{"@type":"ListItem","position":2,"name":"Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 4Q25"}]},{"@type":"WebSite","@id":"https:\/\/matribhumisamachar.com\/en\/#website","url":"https:\/\/matribhumisamachar.com\/en\/","name":"Matribhumi Samachar English","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/matribhumisamachar.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/0a61403f4baf9627e92218b53a1e65f1","name":"Saransh Kanaujia","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/matribhumisamachar.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/45a8b03a1b1bb8255014f5e62f9cfea0eb8a9f7a6a604f9879038df08da23cea?s=96&d=mm&r=g","caption":"Saransh Kanaujia"},"description":"Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.","sameAs":["https:\/\/matribhumisamachar.com\/en"],"url":"https:\/\/matribhumisamachar.com\/en\/author\/matribhumisamachar\/"}]}},"_links":{"self":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/66393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/comments?post=66393"}],"version-history":[{"count":1,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/66393\/revisions"}],"predecessor-version":[{"id":66430,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/posts\/66393\/revisions\/66430"}],"wp:attachment":[{"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/media?parent=66393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/categories?post=66393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/matribhumisamachar.com\/en\/wp-json\/wp\/v2\/tags?post=66393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}